We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+0.11%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$851M
AUM Growth
-$105M
Cap. Flow
+$44.2M
Cap. Flow %
5.19%
Top 10 Hldgs %
47.53%
Holding
835
New
170
Increased
157
Reduced
172
Closed
270

Top Buys

Rank Stock Value
1
KVSC
Khosla Ventures Acquisition Co. III Class A Common Stock
KVSC
+$24.3M
2
STOK icon
Stoke Therapeutics
STOK
+$22.8M
3
TIOA
Tio Tech A Class A Ordinary Share
TIOA
+$22.1M
4
SCPH
scPharmaceuticals
SCPH
+$20.6M
5
AAC
Ares Acquisition Corporation
AAC
+$13.3M

Top Sells

Rank Stock Value
1
DCP
DCP Midstream, LP
DCP
+$58.8M
2
SCPL
SciPlay Corporation Class A Common Stock
SCPL
+$25.2M
3
CTLP
Cantaloupe
CTLP
+$12.3M
4
INVZ icon
Innoviz Technologies
INVZ
+$10.9M
5
KAIR
Kairos Acquisition Corp. Class A Ordinary Shares
KAIR
+$8.76M

Sector Composition

Rank Sector Weight
1 Healthcare 38.46%
2 Financials 25.66%
3 Materials 12.69%
4 Consumer Discretionary 4.54%
5 Technology 2.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALSAW
401
DELISTED
Alpha Star Acquisition Corp Warrants
ALSAW
$8.65K ﹤0.01%
626,711
– –
KRNLW
402
DELISTED
Kernel Group Holdings, Inc. Warrants
KRNLW
$8.61K ﹤0.01%
74,866
-17,300
-19% -$1.76K
PLAOW
403
DELISTED
Patria Latin American Opportunity Acquisition Corp. Warrant
PLAOW
$8.48K ﹤0.01%
93,833
-1,400
-1% -$130
VLD.WS
404
DELISTED
Velo3D, Inc. Redeemable warrants, each Warrant exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50
VLD.WS
$8.46K ﹤0.01%
21,900
-8,139
-27% -$3.19K
LCAHW
405
DELISTED
Landcadia Holdings IV, Inc. Warrant
LCAHW
$8.23K ﹤0.01%
50,000
-96,879
-66% -$14.7K
EUCRW
406
DELISTED
Eucrates Biomedical Acquisition Corp. Warrant
EUCRW
$8.2K ﹤0.01%
202,371
+80,114
+66% +$5.53K
MCAAW
407
DELISTED
Mountain & Co. I Acquisition Corp. Warrant
MCAAW
$8.19K ﹤0.01%
126,048
-98,952
-44% -$5.8K
HCMAW
408
DELISTED
HCM Acquisition Corp Warrant
HCMAW
$8.17K ﹤0.01%
257,841
+22,756
+10% +$553
HSPOW
409
DELISTED
Horizon Space Acquisition I Corp Warrant
HSPOW
$8.15K ﹤0.01%
+197,750
New +$9.04K
VLATW
410
DELISTED
Valor Latitude Acquisition Corp. Warrant
VLATW
$8.14K ﹤0.01%
203,471
-324,864
-61% -$12.5K
HAIAW
411
DELISTED
Healthcare AI Acquisition Corp. Warrants
HAIAW
$8.08K ﹤0.01%
+50,194
New +$4.85K
SKGRW
412
DELISTED
SK Growth Opportunities Corporation Warrant
SKGRW
$8.02K ﹤0.01%
50,000
-69,290
-58% -$12.4K
STLNW
413
Starling Oncology, Inc. Warrant
STLNW
$4.99M
$7.83K ﹤0.01%
120,300
+200
+0.2% +$25
SHPWW
414
DELISTED
Shapeways Holdings, Inc. Warrants
SHPWW
$7.77K ﹤0.01%
353,221
– –
CITEW
415
DELISTED
Cartica Acquisition Corp Warrant
CITEW
$7.65K ﹤0.01%
+107,714
New +$9.73K
PSPC.WS
416
DELISTED
Post Holdings Partnering Corporation Redeemable Warrants, each whole warrant exercisable for one share of Series A common stock at an exercise price of $11.50
PSPC.WS
$7.5K ﹤0.01%
50,000
-50,000
-50% -$5.64K
LTCHW
417
DELISTED
Latch, Inc. Warrant expiring 6/4/2026
LTCHW
$7.48K ﹤0.01%
125,745
+77,621
+161% +$6.06K
NOVVR
418
DELISTED
Nova Vision Acquisition Corp. Rights
NOVVR
$7.25K ﹤0.01%
25,000
-35,600
-59% -$6.34K
APCA.WS
419
DELISTED
AP Acquisition Corp Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
APCA.WS
$7.21K ﹤0.01%
65,000
+27,211
+72% +$2.7K
TBCPW
420
DELISTED
Thunder Bridge Capital Partners III Inc. Warrant
TBCPW
$7.21K ﹤0.01%
60,000
-8,000
-12% -$922
XBPEW
421
XBP Europe Holdings Warrant
XBPEW
$7.18K ﹤0.01%
68,487
+300
+0.4% +$17
CETUW
422
DELISTED
Cetus Capital Acquisition Corp. Warrant
CETUW
$7K ﹤0.01%
+140,100
New +$8.76K
VBOCW
423
DELISTED
Viscogliosi Brothers Acquisition Corp Warrant
VBOCW
$6.9K ﹤0.01%
98,600
-1,400
-1% -$84
BOCNW
424
DELISTED
Blue Ocean Acquisition Corp Warrants
BOCNW
$6.87K ﹤0.01%
76,202
+58,222
+324% +$4.94K
FHLTW
425
DELISTED
Future Health ESG Corp. Warrant
FHLTW
$6.86K ﹤0.01%
114,360
+100,000
+696% +$6.11K
15 16
17
18 19

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q1 2023 Portfolio in Review

As of Q1 2023, Cowen and Company held 835 positions worth $851M, down 11% from $956M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Cowen and Company deployed $44.2M of net new capital in Q1 2023, opening 170 new positions and adding to 157 existing holdings. Its largest new stake was Khosla Ventures Acquisition Co. III Class A Common Stock: 2,410,664 shares worth $24.5M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 37% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was SciPlay Corporation Class A Common Stock, an estimated $25.2M trimmed.

  • Cowen and Company's largest Q1 2023 buy was Khosla Ventures Acquisition Co. III Class A Common Stock: 2,410,664 shares worth $24.5M.
  • Cowen and Company added most to Stoke Therapeutics in Q1 2023, an estimated $22.8M increase.
  • Cowen and Company's biggest Q1 2023 reduction was SciPlay Corporation Class A Common Stock, cutting an estimated $25.2M.
  • Cowen and Company fully exited DCP Midstream, LP in Q1 2023, selling an estimated $58.8M.
  • Cowen and Company's ten largest holdings make up 48% of its $851M portfolio in Q1 2023.
  • Cowen and Company opened 170 new positions and closed 270 in Q1 2023.
  • Cowen and Company's portfolio value fell 11% quarter-over-quarter to $851M.

Based on Cowen and Company's 13F filing for Q1 2023, filed 9 May 2023.